This innovative Artificial Intelligence (AI) technology involves the digitization of traditional glass slides which enables pathologists to access, analyze, and share high-resolution whole-slide images (WSI) of tissue specimens in a digital format.
The research demonstrates that AI-based immune tests like Immunoscore (IS) and Immunoscore-Immune Checkpoint (IS-IC) are powerful for improving how we diagnose, predict, and treat cancer by analyzing the immune environment of tumors. When digital IS assessments were done on slides from colon cancer patients, they were more consistent and reliable than those done by expert pathologists. IS also works better than traditional staging methods, helping to make cancer treatments more effective and improving patient care.
